• Laura A Payne, Laura C Seidman, Tamineh Romero, and Myung-Shin Sim.
• McLean Hospital/Harvard Medical School, Belmont, Massachusetts.
• Pain Med. 2020 Nov 7; 21 (7): 1385-1392.

ObjectiveTo evaluate the feasibility, acceptability, and preliminary efficacy of a mind-body intervention for moderate to severe primary dysmenorrhea (PD).DesignOpen trial (single arm).SettingAcademic medical school.SubjectsA total of 20 young adult women with moderate to severe primary dysmenorrhea were included across four separate intervention groups.MethodsAll participants received five 90-minute sessions of a mind-body intervention and completed self-report measures of menstrual pain, depression, anxiety, somatization, and pain catastrophizing at baseline, post-treatment, and at one-, two-, three-, and 12-month follow-up. Self-report of medication use and use of skills learned during the intervention were also collected at all follow-up points.ResultsParticipants reported significantly lower menstrual pain over time compared with baseline. No changes in anxiety, depression, or somatization were observed, although pain catastrophizing improved over time. Changes in menstrual pain were not associated with changes in medication use or reported use of skills.ConclusionsA mind-body intervention is a promising nondrug intervention for primary dysmenorrhea, and future research should focus on testing the intervention further as part of a randomized clinical trial.© 2020 American Academy of Pain Medicine. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

12 keywords...

hide…